Profile photo Peter van de Ven

Peter van de Ven

Associate Professor

Strategic program(s):

Biography

I am an associate professor in clinical trial methodology and statistics working within the Department of Data Science and Biostatistics of the Julius Center where I lead the Clinical Trial Methodology & Statistical Consultation team. My interests lie in innovative clinical trial methodology (both development and application) and adaptive methods, trials-within cohorts and trials in rare diseases in particular. I am the Trial Methodology Lead for U-TRIAL and workpackage leader for the Adaptive Trial Platform WP in the ONCODE-ACCELERATOR growthfund project. I am the chair of the UMC Utrecht's internal DSMB.  I also act as a methodology assessor (seconded) for the Dutch Medicines Evaluation Board (College ter Beoordeling van Geneesmiddelen: CBG-MEB). 

From July 2009 until April 2021 I worked at the Amsterdam UMC location VUmc as a researcher, a statistical consultant and methodology member of the hospital's institutional review board (METc).

I hold a PhD degree in Statistics from Eindhoven University of Technology (2007), a M.A. degree in Health Psychology from Tilburg University (2003) and a M.Sc. degree in Engineering Mathematics from Eindhoven University of Technology (2001). I have held postdoctoral research positions at the Southampton Statistical Sciences Research Institute S3RI (2007-2008) and TNO Quality of Life (2008-2009).

Strategic program(s):

Contact

Research groups

Julius Center Research Program Cancer

Research aim

Our mission is to drive impactful innovation for cancer prevention, diagnosis, prognosis, treatment, and care through interdisciplinary research, fostering collaboration among researchers across disciplines within the Julius Center and beyond.

Go to group

Recent publications

Breaking the chains of lipoprotein lipase deficiency Bibiche den Hollander, Marion M. Brands, Ilse J.M. Nijhuis, Lous J.A.E. Doude van Troostwijk, Peter van Essen, Ageeth H. Hofsteenge, Bart G. Koot, Annelieke R. Müller, Laura A. Tseng, Erik S.G. Stroes, Peter M. van de Ven, Albert Wiegman, Clara D.M. van Karnebeek
Molecular Genetics and Metabolism, 2024, vol. 142
Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer Dieuwke R Mink van der Molen, Marilot C T Batenburg, Wiesje Maarse, Desiree H J G van den Bongard, Annemiek Doeksen, Marjoleine Y de Lange, Carmen C van der Pol, Daniel J Evers, Corine A Lansdorp, Jacco van der Laan, Peter M van de Ven, Femke van der Leij, Helena M Verkooijen
JAMA Oncology, 2024, vol. 10, p.464-474
Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation Bibiche den Hollander, Marieke Rothuizen-Lindenschot, Lisa Geertjens, Frédéric M. Vaz, Marion M. Brands, Hoang Lan Le, Agnies M. van Eeghen, Peter M. van de Ven, Martina C. Cornel, Bart A.W. Jacobs, Hilgo Bruining, Clara D. van Karnebeek
Contemporary Clinical Trials Communications, 2024, vol. 38
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome A. R. Müller, B. den Hollander, P. M. van de Ven, K. C.B. Roes, L. Geertjens, H. Bruining, C. D.M. van Karnebeek, F. E. Jansen, M. C.Y. de Wit, L. W. ten Hoopen, A. B. Rietman, B. Dierckx, F. A. Wijburg, E. Boot, M. M.G. Brands, A. M. van Eeghen
BMC Psychiatry, 2024, vol. 24
Nosocomial RSV-related In-hospital Mortality in Children <5 Years Yvette N Löwensteyn, Joukje E Willemsen, Natalie I Mazur, Nienke M Scheltema, Nynke C J van Haastregt, Amber A A Ten Buuren, Ichelle van Roessel, Dunja Scheepmaker, Harish Nair, Peter M van de Ven, Louis J Bont,
The Pediatric infectious disease journal, 2023, vol. 42, p.1-7
Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients K. R.J. Kistemaker, A. de Graeff, M. Crul, G. de Klerk, P. M. van de Ven, M. P. van der Meulen, L. van Zuylen, M. A.H. Steegers
BMC Palliative care, 2023, vol. 22, p.1-8

External positions

Member of the grant review board of the Dutch Cancer Society (KWF)

Methodology asssessor (seconded), Dutch Medicines Evaluation Board (MEB), Utrecht

Statistical reviewer (paid) for Diabetologia